Harvard Bioscience Inc. has amended its bylaws to reduce the quorum requirement for stockholder meetings from a majority to one-third of the shares entitled to vote. The change was approved by the Board of Directors and became effective immediately upon adoption.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-000343), on January 20, 2026, and is solely responsible for the information contained therein.

